Double-blind treatment of major depression with dehydroepiandrosterone.
about
Neurosteroids: endogenous role in the human brain and therapeutic potentialsReproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?The dominance behavioral system and psychopathology: evidence from self-report, observational, and biological studiesThe role of reproductive hormones in postpartum depressionNeuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depressionThe association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder.Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and MicrogliaThe psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment.Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.Maximizing resilience through diverse levels of inquiry: Prevailing paradigms, possibilities, and priorities for the future.Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women.No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These ConditionsDehydroepiandrosterone and age-related cognitive decline.Reproductive aging, sex steroids, and mood disordersSex hormones and mood in the perimenopause.Acute and chronic stress increase DHEAS concentrations in rhesus monkeys.Off-label use of hormones as an antiaging strategy: a reviewNeurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?Aging of the hypothalamic-pituitary-adrenal axis in nonhuman primates with depression-like and aggressive behavior.Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.Pregnenolone sulfate as a modulator of synaptic plasticity.Why egalitarianism might be good for your health: physiological thriving during stressful intergroup encounters.Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers.Mood disorders and complementary and alternative medicine: a literature review.DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder.Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionHigher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.Neuroactive Steroids: Receptor Interactions and Responses.Neuroactive Steroids: Receptor Interactions and Responses.A DNA Methylation Signature of Addiction in T Cells and Its Reversal With DHEA Intervention
P2860
Q24632113-DABE1B3F-3BD6-4402-85B7-C48F0815C04CQ24650090-5FDC19C5-31DD-4483-BED3-D370F0354000Q26824098-1BE68EE9-03D6-44BC-9F3D-91D0121FBBD8Q26849873-CB50D6A1-4662-4ABB-8C66-FA1D97FD4BF9Q28220405-4E4D0A11-CB62-463C-88C1-74BA929BAB27Q30433786-AC0D8FB8-0BEA-4B5D-9CCD-9E438DCFBAADQ30452038-275AE2A5-4228-4C23-8413-499CFD430A32Q30473425-CA7A5294-6713-41DF-AF9B-EE44AB023093Q30477689-4DED96D5-D4AB-44CE-9646-CD21AF21CFD9Q30498916-85F2E9BF-EEB3-43B5-B449-BEB5497E8339Q33628099-268B02D6-1CAC-45F0-B5DE-D5A6D1356486Q33658675-6D04E4F8-3276-4E8A-8AEA-823BB4957BF6Q33692587-9D0DB125-4756-4270-ABDB-7A8C315F7004Q33820067-83B145D3-ABE5-4C38-8862-107AFB16B269Q33938538-50B3AE78-D087-4065-A43E-18DACC70E0F2Q33952568-6E08B405-ED6C-40C8-884E-821AC43D08ECQ33976165-2DC46DAE-F6CF-4198-B243-0864EAC3F5D8Q34054017-7F6F3293-AD78-4D60-BC37-603CDF75D5FFQ34424926-E1A68E86-2520-4D0F-A29E-26000363BE30Q34795242-582328F6-9275-4B4F-BB77-F8098A4EE4CCQ35505547-70C51209-E164-4A9D-9D2E-DF234ACEE9F2Q36224315-19A5096D-F70E-4A85-A2BF-1D5747D3B31FQ36726459-7195EC2D-CCDD-493B-8785-5517C7751D03Q36823260-8EE78486-8719-47FC-BB9C-8C668AA7F3DEQ36863056-E9C509D6-8F57-44EC-9F96-313275F39C53Q37030186-D4BF595F-21FE-4B5B-905D-E26D4A40F589Q37102070-1C3F8F7B-5B75-47F0-B124-2AE1D3905FCAQ37300547-6E8C78AC-098B-4638-A551-053CE421F54AQ37633146-2B98DA71-1468-4C91-B3D9-37419CDEA23CQ37718994-2D12604C-F857-4CA1-973C-DAF7E230C9F4Q38990885-0123EE56-1423-43A3-B047-1BA729F2BB22Q39050415-40CEDA7D-D7E4-4999-864F-7487F942EDC7Q45812353-4483DC06-20A8-4CCE-B481-F56B09396D25Q46750998-03A1D80B-3526-4D10-9DDF-BB5EB2BB9D4FQ58754330-E0FE0888-AA56-416A-A9FF-6A526E224211
P2860
Double-blind treatment of major depression with dehydroepiandrosterone.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Double-blind treatment of major depression with dehydroepiandrosterone.
@en
type
label
Double-blind treatment of major depression with dehydroepiandrosterone.
@en
prefLabel
Double-blind treatment of major depression with dehydroepiandrosterone.
@en
P2093
P356
P1476
Double-blind treatment of major depression with dehydroepiandrosterone.
@en
P2093
P304
P356
10.1176/AJP.156.4.646
P407
P577
1999-04-01T00:00:00Z